american academy of cardiology glp-1 SOUL findings highlight cardiovascular benefits beyond glycemic control 2025 AHA Scientific Sessions -

Given the high prevalence and adverse prognostic implications of sarcopenic obesity among patients with obesity and type 2 diabetes mellitus, achieving an optimal equilibrium between fat loss and lean mass preservation has emerged as a pivotal challenge in refining GLP-1RA treatment strategies [149]

Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice

Retrieved on 28/07/2022 from Wein, Kavoussi, Novick, Partin, Peters

As a result, there is growing interest in exploring natural compounds like EGCG as potential alternatives or adjuncts to conventional therapies for diabetes prevention and management

N.QianN.QiuB.HuF.ReznikE.et al (2023)